News

The global prevalence of congenital heart disease is higher among women who live in high altitudes, according to a new study being presented at ACC Latin America 2024 in Punta Cana, Dominican Republic.

The PMA application is based on the overwhelmingly positive one-year data from the Company’s C-GUARDIANS pivotal clinical trial that were presented at the Leipzig Interventional Course (LINC) 2024 in May.

Individuals released from jail are more likely to have uncontrolled cardiovascular disease (CVD) risk factors than those released from prison, a new Yale-led study finds.

Silk Road Medical, Inc., is a medical device company that pioneered a new approach for stroke prevention and the treatment of carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization (TCAR).

"The medical device ecosystem needs active clinicians to guide the development process at companies and regulatory agencies," says Aaron V. Kaplan, MD, FACC, FNAI. “This program will provide scholars with a deep understanding of the medical...

HyperVue is the first intravascular imaging technology to combine two important imaging technologies, DeepOCT and NIRS, while optimizing for image quality and procedural efficiency in the cath lab, including no-flush catheter prep, fast and...

Based on data from a national clinical trial led by Children’s Hospital Los Angeles, the FDA approved the Minima stent for neonates, infants, and young children with aortic coarctation or branch pulmonary artery stenosis.

“Our results show that the use of OCT guidance improves clinical outcomes and enhances safety and effectiveness of coronary stenting, reducing cardiac death, MI, stent thrombosis, and the need for revascularisation by 38% in a group of very...